Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Required Dose of Cholecalciferol in Postmenopausal Women
2023-504664-42-02Phase 3Authorised
- Sponsor
- Clínica Palacios
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ibandronic acid in Vitamin D deficiency (VDD) (4 arms), sponsored by Clínica Palacios. Planned start Jun 2023; status: authorised.
02
Drugs
ibandronic acid
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2023-504664-42-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504664-42-02.